Literature DB >> 27471206

High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study.

Anna J Podolanczuk1,2, Elizabeth C Oelsner1,2, R Graham Barr1,3, Eric A Hoffman4, Hilary F Armstrong3, John H M Austin5, Robert C Basner1, Matthew N Bartels6, Jason D Christie7, Paul L Enright8, Bernadette R Gochuico9, Karen Hinckley Stukovsky10, Joel D Kaufman11, P Hrudaya Nath12, John D Newell4, Scott M Palmer13, Dan Rabinowitz14, Ganesh Raghu11, Jessica L Sell1, Jered Sieren15, Sushil K Sonavane12, Russell P Tracy16, Jubal R Watts12, Kayleen Williams11, Steven M Kawut17, David J Lederer18,3.   

Abstract

Evidence suggests that lung injury, inflammation and extracellular matrix remodelling precede lung fibrosis in interstitial lung disease (ILD). We examined whether a quantitative measure of increased lung attenuation on computed tomography (CT) detects lung injury, inflammation and extracellular matrix remodelling in community-dwelling adults sampled without regard to respiratory symptoms or smoking.We measured high attenuation areas (HAA; percentage of lung voxels between -600 and -250 Hounsfield Units) on cardiac CT scans of adults enrolled in the Multi-Ethnic Study of Atherosclerosis.HAA was associated with higher serum matrix metalloproteinase-7 (mean adjusted difference 6.3% per HAA doubling, 95% CI 1.3-11.5), higher interleukin-6 (mean adjusted difference 8.8%, 95% CI 4.8-13.0), lower forced vital capacity (FVC) (mean adjusted difference -82 mL, 95% CI -119--44), lower 6-min walk distance (mean adjusted difference -40 m, 95% CI -1--80), higher odds of interstitial lung abnormalities at 9.5 years (adjusted OR 1.95, 95% CI 1.43-2.65), and higher all cause-mortality rate over 12.2 years (HR 1.58, 95% CI 1.39-1.79).High attenuation areas are associated with biomarkers of inflammation and extracellular matrix remodelling, reduced lung function, interstitial lung abnormalities, and a higher risk of death among community-dwelling adults.
Copyright ©ERS 2016.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27471206      PMCID: PMC5089905          DOI: 10.1183/13993003.00129-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  55 in total

1.  Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  J Jeffrey Carr; Jennifer Clark Nelson; Nathan D Wong; Michael McNitt-Gray; Yadon Arad; David R Jacobs; Stephan Sidney; Diane E Bild; O Dale Williams; Robert C Detrano
Journal:  Radiology       Date:  2005-01       Impact factor: 11.105

2.  Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.

Authors:  Thomas J Richards; Naftali Kaminski; Fred Baribaud; Susan Flavin; Carrie Brodmerkel; Daniel Horowitz; Katherine Li; Jiin Choi; Louis J Vuga; Kathleen O Lindell; Melinda Klesen; Yingze Zhang; Kevin F Gibson
Journal:  Am J Respir Crit Care Med       Date:  2012-01-01       Impact factor: 21.405

3.  Alveolar epithelial cell disintegrity and subsequent activation: a key process in pulmonary fibrosis.

Authors:  Moisés Selman; Annie Pardo
Journal:  Am J Respir Crit Care Med       Date:  2012-07-15       Impact factor: 21.405

4.  Interstitial lung abnormalities and reduced exercise capacity.

Authors:  Tracy J Doyle; George R Washko; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; Miguel J Divo; Bartolome R Celli; Frank C Sciurba; Edwin K Silverman; Hiroto Hatabu; Ivan O Rosas; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2012-01-20       Impact factor: 21.405

5.  Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women.

Authors:  Edmund A Bermudez; Nader Rifai; Julie Buring; JoAnn E Manson; Paul M Ridker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

6.  Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis.

Authors:  K E Greene; T E King; Y Kuroki; B Bucher-Bartelson; G W Hunninghake; L S Newman; H Nagae; R J Mason
Journal:  Eur Respir J       Date:  2002-03       Impact factor: 16.671

7.  Percent emphysema, airflow obstruction, and impaired left ventricular filling.

Authors:  R Graham Barr; David A Bluemke; Firas S Ahmed; J Jeffery Carr; Paul L Enright; Eric A Hoffman; Rui Jiang; Steven M Kawut; Richard A Kronmal; João A C Lima; Eyal Shahar; Lewis J Smith; Karol E Watson
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

8.  MUC5B promoter polymorphism and interstitial lung abnormalities.

Authors:  Gary M Hunninghake; Hiroto Hatabu; Yuka Okajima; Wei Gao; Josée Dupuis; Jeanne C Latourelle; Mizuki Nishino; Tetsuro Araki; Oscar E Zazueta; Sila Kurugol; James C Ross; Raúl San José Estépar; Elissa Murphy; Mark P Steele; James E Loyd; Marvin I Schwarz; Tasha E Fingerlin; Ivan O Rosas; George R Washko; George T O'Connor; David A Schwartz
Journal:  N Engl J Med       Date:  2013-05-21       Impact factor: 91.245

9.  MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.

Authors:  Ivan O Rosas; Thomas J Richards; Kazuhisa Konishi; Yingze Zhang; Kevin Gibson; Anna E Lokshin; Kathleen O Lindell; Jose Cisneros; Sandra D Macdonald; Annie Pardo; Frank Sciurba; James Dauber; Moises Selman; Bernadette R Gochuico; Naftali Kaminski
Journal:  PLoS Med       Date:  2008-04-29       Impact factor: 11.069

10.  Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit.

Authors:  I Kushner; G Feldmann
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more
  61 in total

1.  Interstitial lung abnormalities and self-reported health and functional status.

Authors:  Gisli Thor Axelsson; Rachel K Putman; Tetsuro Araki; Sigurdur Sigurdsson; Elias Freyr Gudmundsson; Gudny Eiriksdottir; Thor Aspelund; Ezra R Miller; Lenore J Launer; Tamara B Harris; Hiroto Hatabu; Vilmundur Gudnason; Gary Matt Hunninghake; Gunnar Gudmundsson
Journal:  Thorax       Date:  2018-01-09       Impact factor: 9.139

2.  In Rotterdam, size really does matter: implications of pulmonary artery enlargement on mortality.

Authors:  Aline N Zouk; J Michael Wells
Journal:  Eur Respir J       Date:  2017-06-15       Impact factor: 16.671

3.  High-Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community-Dwelling Adults.

Authors:  Anna J Podolanczuk; Elizabeth C Oelsner; R Graham Barr; Elana J Bernstein; Eric A Hoffman; Imaani J Easthausen; Karen Hinckley Stukovsky; Arindam RoyChoudhury; Erin D Michos; Ganesh Raghu; Steven M Kawut; David J Lederer
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

4.  Collagen biomarkers and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Purnema Madahar; Daniel A Duprez; Anna J Podolanczuk; Elana J Bernstein; Steven M Kawut; Ganesh Raghu; R Graham Barr; Myron D Gross; David R Jacobs; David J Lederer
Journal:  Respir Med       Date:  2018-06-06       Impact factor: 3.415

5.  Objectively Measured Chronic Lung Injury on Chest CT.

Authors:  Rola Harmouche; Samuel Y Ash; Rachel K Putman; Gary M Hunninghake; Ruben San Jose Estepar; Fernando J Martinez; Augustine M Choi; David A Lynch; Hiroto Hatabu; MeiLan K Han; Russell P Bowler; Ravi Kalhan; Ivan O Rosas; George R Washko; Raul San Jose Estepar
Journal:  Chest       Date:  2019-06-22       Impact factor: 9.410

6.  Angiotensin Receptor Blockers and Subclinical Interstitial Lung Disease: The MESA Study.

Authors:  Whitney D Gannon; Michaela R Anderson; Anna J Podolanczuk; Steven M Kawut; Erin D Michos; Vincent Cottin; Michael Kreuter; Ganesh Raghu; R Graham Barr; David J Lederer
Journal:  Ann Am Thorac Soc       Date:  2019-11

7.  Air pollution and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA) air-lung study.

Authors:  Coralynn Sack; Sverre Vedal; Lianne Sheppard; Ganesh Raghu; R Graham Barr; Anna Podolanczuk; Brent Doney; Eric A Hoffman; Amanda Gassett; Karen Hinckley-Stukovsky; Kayleen Williams; Steve Kawut; David J Lederer; Joel D Kaufman
Journal:  Eur Respir J       Date:  2017-12-07       Impact factor: 16.671

8.  Reference values for high attenuation areas on chest CT in a healthy, never-smoker, multi-ethnic sample: The MESA study.

Authors:  Imaani Easthausen; Anna Podolanczuk; Eric Hoffman; Steven Kawut; Elizabeth Oelsner; John S Kim; Ganesh Raghu; Karen Hinckley Stukovsky; Susan Redline; Robyn L McClelland; R Graham Barr; David J Lederer
Journal:  Respirology       Date:  2020-02-17       Impact factor: 6.424

9.  Pulmonary fibrosis screening: quantifying the psychological impact.

Authors:  Chad A Newton
Journal:  Thorax       Date:  2021-02-23       Impact factor: 9.139

10.  Circulating adhesion molecules and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Claire F McGroder; Carrie P Aaron; Suzette J Bielinski; Steven M Kawut; Russell P Tracy; Ganesh Raghu; R Graham Barr; David J Lederer; Anna J Podolanczuk
Journal:  Eur Respir J       Date:  2019-09-30       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.